Huntsman Targets $300 Million in Synergies; $100 Million Tied to Chlorine Contracts
Huntsman expects 2026 EBITDA to improve by over $100M from 2025. The company targets $300M in synergies from its merger with Olin, expected to close in early 2027, and an additional $100M from chlorine contracts. Huntsman reported an $82M free cash flow inflow in Q3 and anticipates a substantial Q4 cash inflow.
How this was made

The 30-second read
Why it matters
The announced EBITDA improvement and synergy targets provide fresh guidance that could shift valuation.
Market read
New guidance and merger synergies are material for investors and may influence HUN's stock price ahead of 2026 earnings.
What to watch
Potential regulatory scrutiny of the Huntsman-Olin merger could delay or reduce expected benefits.
Background
Huntsman Corp (HUN) is a U.S.-listed specialty chemicals company planning to merge with Olin Corp.
Ticker impact
Huntsman disclosed expected 2026 EBITDA improvement of >$100M and $300M synergies from its pending merger with Olin.
potential upside as investors price in higher EBITDA and synergy benefits
The disclosed numbers are new, material, and directly affect earnings expectations.
Market effects
Chemicals sector may see broader valuation lift as merger synergies become a benchmark.
U.S. chemicals market could benefit from perceived consolidation benefits.
Limited to industry peers; no broad macro impact.
Counterpoint
If integration costs exceed expectations, the synergy estimate could be overstated, pressuring the stock.
Key entities
- CompanyHuntsman Corp
Specialty chemicals producer reporting new guidance.
- CompanyOlin Corp
Merger partner of Huntsman.


